جستجوی استاد راهنمای دانشگاهی

Christoph F. Schmidt is the Hertha Sponer Distinguished Professor of Physics at Duke University, affiliated with Trinity College of Arts & Sciences and Pratt School of Engineering. His academic roles include Professor of Physics, Biomedical Engineering, and Mechanical Engineering/Material Science, as well as Co-Director of the Duke Materials Initiative. He holds a D.R. from the Technical University of Munich (1988). His research focuses on biophysics, mechanobiology, and materials science, with emphasis on cellular mechanics, cytoskeletal networks, and active matter systems. Key projects include studying cell membrane tension dynamics, viral capsid mechanics, and microtubule motor proteins. He leads the Schmidt Lab, pioneering tools like DeepProjection for 3D tissue imaging and DNA-based force sensors. Notable recognitions include the Hertha Sponer Distinguished Professorship and inclusion in Duke’s 2019 Distinguished Faculty Rank. He teaches advanced biophysics courses and advises on grants like the NIH-funded University Training Program in Biomolecular Engineering. Recent publications (2023–2025) explore nonlinear cell wall mechanics, stochastic sarcomere behavior, and machine learning in microscopy. His work bridges physics, engineering, and biology, with applications in cancer research, tissue regeneration, and nanotechnology. Collaborations span Duke’s interdisciplinary initiatives, reflecting his commitment to advancing quantitative biology and materials science.

• Biophysics
• Cell Biology
• Materials Science
• +۳ مورد دیگر

Prof. Floris Foijer is a Full Professor at the University of Groningen's Faculty of Medical Sciences and UMCG, leading the Laboratory of Genomic Instability in Development and Disease. His research focuses on the consequences of aneuploidy in cancer, particularly how cancer cells exploit genomic instability for survival and proliferation. He holds roles as Director of the UMCG Functional Genomics Centre and Program Leader at the Kolff Institute's 'Regenerate' program. Foijer obtained his PhD from the Netherlands Cancer Institute (2006) and completed postdoctoral training at Harvard Medical School (2007-2009) and the Wellcome Trust Sanger Institute (2009-2011). He has pioneered murine models for chromosomal instability and developed CRISPR-based technologies. Key research areas include genomic instability's role in cancer evolution, therapeutic vulnerabilities in aneuploid cancers, and the link between chromosomal instability and aging. His work has been recognized with prestigious awards, including the Vici Grant (2023) and EMBO Fellowship (2009). Foijer collaborates internationally, contributing to projects like the ERIBA/iPSC/CRISPR facility supporting genome editing research. His lab's findings have advanced understanding of aneuploidy-driven cancer mechanisms and potential targeted therapies. Scientific Awards: - Vici Grant (2023) - EMBO Long-Term Postdoctoral Fellowship (2009) - Dutch Cancer Society Postdoctoral Fellowship (2007) Grants and Activities: - Director of UMCG Functional Genomics Centre (iPSC/CRISPR facility) - Member of KWF Assessment Board and Genomic Integrity Centre Scientific Board - Supervised 17 PhD/Master’s theses (noted in his profile) Labs/Teams: - Laboratory of Genomic Instability in Development and Disease - ERIBA/iPSC/CRISPR facility collaborations

• Cancer Biology
• Genetic Instability
• Cell Cycle Control
• +۵ مورد دیگر

Dr. Naisana Seyedasli is a Senior Lecturer in the School of Medical Sciences at the University of Sydney, affiliated with the Centre for Cancer Research at the Westmead Institute for Medical Research. Her research focuses on stem cell biology, cancer therapy resistance, and tumor heterogeneity. She holds a PhD in Molecular Biology from the International Max Planck Research School (2008) and has conducted postdoctoral work at the Victor Chang Cardiac Research Institute. Education : PhD in Molecular Biology (2008), International Max Planck Research School, University of Goettingen Max Planck Research Fellowship (2004–2008) DAAD Scholarship (2003–2004) Research Interests : Her work explores regulatory networks in embryonic/adult stem cells, mechanisms of therapy resistance in epithelial carcinomas, and 3D tumor modeling. She uses single-cell technologies to study tumor heterogeneity and employs approaches like CRISPR and bioinformatics. Grants & Awards : 2022: Dr. Poyner Award (Australian Dental Research Foundation) 2021: Makers and Shapers Award (University of Sydney) 2018: ASMR Research Excellence Award Over 10 prestigious fellowships/awards since 2003 Collaborations : International partnerships include the St. John's Research Institute (India) and the Center for Cellular & Molecular Biology (India). She leads projects on stem cell plasticity and drug resistance in cancers. Teaching : Supervises PhD/MPhil students in cancer biology and regenerative medicine. Current projects include developing 3D tumor models and understanding resistance mechanisms.

• Cancer Biology
• Stem Cell Biology
• Cellular Signaling Pathways
• +۵ مورد دیگر

Graciela Krikun is a Research Scientist at Yale University’s Yale School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences. She holds a PhD from Mount Sinai School of Medicine (1984). Her research focuses on endometrial angiogenesis, reproductive immunology, and endometrial stem cell biology. She developed the ICON3 molecule for endometriosis treatment, collaborates with Dr. Gil Mor on maternal innate immunity during implantation, and studies stem cell niches with Dr. Hugh Taylor. Her work integrates molecular mechanisms of hormonal regulation, immunotherapy, and tissue regeneration. Key collaborations include projects with Charles Lockwood, Hugh Taylor, and Ramanaiah Mamillapalli. NIH grants supported her earlier work on matrix metalloproteinase regulation in endometrial tissues. Research spans from preclinical models to clinical translation, addressing conditions like endometriosis and placental dysfunction.

• Reproductive Biology
• Endocrinology
• Immunology
• +۳ مورد دیگر

Sudhir Perincheri, MD, PhD, is an Assistant Professor of Pathology at Yale School of Medicine and serves as Director of Digital Pathology. He completed his residency in Anatomic Pathology/Clinical Pathology as well as fellowship training in hematopathology, renal and genitourinary pathology in the Departments of Pathology and Laboratory Medicine at Yale. Dr. Perincheri's research focuses on the application of emerging tools in anatomic pathology, with particular expertise in digital pathology. His work bridges clinical pathology with technological innovations, especially in the transition from traditional glass slides to digital imaging systems that may eventually incorporate artificial intelligence algorithms for more accurate disease diagnosis. His research portfolio shows a strong emphasis on renal pathology, transplant pathology, and genitourinary tumors. Analysis of his recent publications reveals a consistent focus on glomerular diseases, mechanisms of transplant rejection, and diagnostic innovations in hematopathology. His work often involves collaborative research with other Yale faculty in applying advanced imaging techniques like MultiPhoton Microscopy to renal and prostate pathology. Scientific Recognition Postdoctoral Fellowship Award from Juvenile Diabetes Research Foundation (2006) Dr. Perincheri maintains active clinical responsibilities, regularly diagnosing complex cases involving blood cancers, kidney disorders, and genitourinary malignancies. His role as Director of Digital Pathology places him at the forefront of technological transformation in the field, working on the development and implementation of digital imaging systems that could revolutionize how pathology is practiced. He serves on several professional committees including the ECOG-ACRIN Multiple Myeloma Committee, ECOG-ACRIN Laboratory Science and Pathology Committee, Medical Record and Clinical Information Committee, and the College of American Pathology Digital and Computational Pathology Committee. These roles demonstrate his leadership in advancing pathology practice standards and digital transformation in the field.

• Pathology
• Digital Pathology
• Transplant Pathology
• +۶ مورد دیگر

Liwen Ren is a Research Fellow in Pharmacology at the Yale School of Medicine, Yale University. Their research focuses on cancer biology and drug development, particularly in glioblastoma, lung carcinoma, and pancreatic cancer. Key interests include tumor metabolism, ferroptosis regulation, and immune mechanisms in cancer progression. Ren has contributed to studies on therapeutic targets such as MELK kinase, Skp2 inhibitors, and apolipoprotein C1 (APOC1) biomarkers. Publications highlight advancements in drug design (e.g., S670 derivative for glioblastoma), epigenetic therapies, and combinatorial treatments for metabolic diseases. Collaborative work spans molecular biology, pharmacology, and computational drug screening. No scientific awards are explicitly mentioned in the provided texts. Current roles involve advancing preclinical drug candidates and investigating cellular pathways in oncogenesis. No listed advisees or grants are noted in the current profile.

• Cancer Biology
• Oncology
• Pharmacology
• +۳ مورد دیگر

Professor Lewis Francis is an Associate Professor in Reproductive Biology and a core member of the Gynaecological Oncology Research Group (RBGO) at Swansea University Medical School. He leads the Biophysics and Epigenetics research programs, focusing on advanced drug delivery systems and cellular heterogeneity in complex microenvironments. His work integrates cell and molecular biophysics with regenerative medicine, aiming to identify therapeutic targets through biomechanical and epigenetic analyses. Dr. Francis serves as Programme Director for the Nanomedicine MSc and holds roles as Director of ACNM and Deputy Director of the CALIN project. His teaching spans undergraduate courses in Genetic Analysis, Medical Genetics, and Carbohydrate Metabolism, alongside supervising Genetic and Biochemistry MSci students. He collaborates extensively with institutions like Houston Methodist Hospital Research Institute and the Morgan Advanced Studies Institute (MASI). Research interests include biomarker expression, gene regulation networks, and cell-matrix interactions. His lab develops high-resolution microscopy and bioinformatics tools to study epigenetic responses in cancer cells. Notable projects involve 3D biomimetic models for fibrosis studies and selenium nanoparticle impacts on cancer biomechanics. Dr. Francis' work bridges nanomedicine and clinical applications, with a focus on ovarian and endometrial cancers. He advocates for interdisciplinary approaches combining biophysics, AI, and regenerative medicine to address unmet clinical needs in reproductive and oncological fields.

• Cell and molecular biophysics
• High resolution microscopy
• Reproductive Biology
• +۷ مورد دیگر

Dr. Eoin (J.V.) Fleming is a Lecturer in Biochemistry and Cell Biology at University College Cork , with a joint appointment between the School of Biochemistry and the School of Pharmacy. He directs postgraduate programs in the BioPharmaceutical sector and has a research focus on protein quality control at the endoplasmic reticulum (ER), particularly in relation to Hereditary Hemochromatosis and ubiquitin conjugating enzymes . BSc (Biochemistry, UCC, 1992) PhD (University of Aberdeen, 1996) His research investigates how proteins like HFE (linked to iron metabolism) and HDC (histamine synthesis) are regulated through degradation pathways. Projects include characterizing UBE2J2 proteasomal degradation and ER stress modulation in disease contexts. Funding includes grants from the Health Research Board (€244,358) and Irish Research Council (€24,000), with over €1.4 million total career research income. Recent publications highlight his work on ERAD pathways , histamine-related carcinogenesis , and iron metabolism regulation . Collaborations span institutions in Portugal, the USA, and Saudi Arabia. Supervision includes 3 PhD graduates ( Emer Cantillon , Shuet Yin Selina Lam , Louise Foley ) and 4 MSc graduates, with 5 current postgraduate students. He has served as an internal examiner for 15 PhD vivas and held leadership roles in the Irish Area Biochemical Society (Chair, 2013–2018). Teaching responsibilities include modules BC4010, BC4012 for Biochemistry, and PF6210, PF6616 for Pharmacy. He coordinates postgraduate programs such as the MSc in BioPharma Processing and CPD Certificates in BioPharmaceutical Technologies .

• Biochemistry
• Cell Biology
• Molecular Biology
• +۴ مورد دیگر

Paolo Macchi is a Full Professor at the University of Trento, holding roles in the Department of Cellular, Computational and Integrative Biology (CIBIO) and the Centre for Medical Sciences (CISMED). He serves as Director of CIBIO and Rector's delegate for Disability Support, and is a member of the University Council. His expertise spans cell biology, molecular biology, neurobiology, and RNA biology, with a focus on RNA localization, translation regulation, and systems biology approaches. He teaches Biologia generale e molecolare , covering cellular structures, molecular mechanisms, and genomic processes. Research highlights include studies on RNA-binding proteins (e.g., RALY, HuD) and their roles in neuronal function, as well as interdisciplinary work on bio-hybrid systems (e.g., TiO2 films, memristive devices) interfacing neurons with materials. His work integrates molecular biology, genomics, and engineering to explore neural mechanisms, cancer biology, and developmental processes. Publications span RNA regulation in telomere dynamics, neuronal excitability, and artificial cell systems. He has developed cell-free systems and functionalized biomaterials for biomedical applications. Collaborative projects include memristive devices for neuromorphic modeling and lipidomics analysis under stress conditions.

• Biology
• Cell Biology
• Molecular Biology
• +۷ مورد دیگر

Klaus Ersfeld is a Professor of Molecular Parasitology at the University of Bayreuth, Germany. He leads the Laboratory of Molecular Parasitology within the Department of Genetics. His research focuses on the cytoskeletal biology of Trypanosoma brucei, particularly the role of microtubule post-translational modifications like polyglutamylation. This work is part of the DFG-funded priority program 'Physics of Parasites' in collaboration with the Department of Experimental Physics (Prof. Matthias Weiss). Ersfeld holds a PhD from the Max Planck Institute for Biophysical Chemistry (Göttingen) and has held academic positions at the University of Hull (Senior Lecturer) and University of Manchester. His expertise spans molecular biology techniques (mutagenesis, RNAi) and cell imaging methods (immunofluorescence, electron microscopy). Recent research emphasizes understanding how microtubule dynamics regulate parasite morphology and life cycle adaptations. Collaborative projects include drug discovery efforts targeting trypanosomes, with publications on antiparasitic gold complexes and organic compounds. His work bridges molecular, structural, and biophysical approaches to parasitology.

• Molecular Parasitology
• Cell Biology
• Microbiology
• +۳ مورد دیگر

Kimchi Adi is a Full Professor at the Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. She has held significant roles, including Head of the Department of Molecular Genetics (2000) and Incumbent of the Helena Rubinstein Chair of Cancer Research (1988). Her research focuses on cell growth and death mechanisms, with implications in molecular genetics and cancer biology. Cancer Research : Emphasis on cellular mechanisms related to apoptosis and cell cycle regulation. Kimchi has received prestigious awards, including the Emet Prize (2012), Lombroso Prize (2006), and Seroussi Award (2002). She is a member of EMBO (2000) and Academia Europaea (2007). Emet Prize Laureate (2012) Lombroso Prize for Cancer Research (2006) Seroussi Award for Cancer Research (2002) Member of EMBO (2000) Member of Academia Europaea (2007) Landau Award for Excellency in Biology and Biotechnology (1999) Milstein Award for Excellency in Cytokine Research (1999) Special EMBO Fellow (1988)

• Cell growth and death
• Molecular Genetics
• Cancer Research
• +۳ مورد دیگر

Dr. Jodi Alexander is a Lecturer in Zoology at Bangor University's School of Environmental and Natural Sciences. Her research focuses on crustacean neuroendocrinology, particularly the hormonal and neuropeptide signaling mechanisms regulating molting (ecdysis) and stress responses in species like the green shore crab (Carcinus maenas). She also contributes to cancer biology research, investigating nanoparticle-based drug delivery systems targeting cancer stem cells in retinoblastoma. Her work integrates molecular biology, transcriptomics, and physiological studies to uncover fundamental biological processes in marine organisms and translational applications in human health. Recent publications highlight her expertise in analyzing neuropeptide systems (e.g., Allatostatin-C, Pigment Dispersing Factors, Corazonin) and their roles in crustacean physiology. Collaborative projects with medical researchers demonstrate her interdisciplinary approach to addressing challenges in oncology and drug delivery. No scientific awards or grants are explicitly mentioned in the provided text. While no advisees are listed, her research contributions suggest potential mentorship roles in postgraduate studies. Her work is centered at Bangor University's School of Environmental and Natural Sciences, with affiliations extending to biomedical collaborations.

• Zoology
• Neuroendocrinology
• Marine Biology
• +۳ مورد دیگر

John Hayward is a Researcher in the Department of Chemistry at the University of Windsor's Faculty of Science. His work spans synthetic chemistry, drug design, and cancer research, with a focus on prostate cancer diagnostics and therapies. Notably, he contributed to the development of imaging agents and anti-cancer vaccines, leveraging techniques like fluorescent probes and boron neutron capture therapy. He also participated in interdisciplinary efforts to enhance lab safety and equity initiatives, earning recognition as an EDI Awards Celebration honoree in 2024. Research interests include the synthesis of bioactive compounds, such as psychedelics and cancer-targeting agents, alongside advancements in materials science and diagnostic tools. His collaborations with industry and academic partners highlight his commitment to bridging laboratory innovation with real-world applications. EDI Contributions: Honored for promoting equity, diversity, and inclusion on campus. Key Technologies: Developed hand sanitizer formulas during the pandemic, advancing practical solutions to public health challenges.

• Chemistry
• Drug Design
• Cancer Research
• +۳ مورد دیگر

Phillip Karpowicz is a Professor in the Department of Biology at the University of Windsor, affiliated with the Faculty of Science and the Great Lakes Institute for Environmental Research. His research focuses on circadian rhythms and their roles in health, disease, and environmental adaptation. Key areas include circadian regulation of intestinal stem cells, cancer initiation, inflammatory bowel disease, and the impacts of circadian misalignment on fish biology. Research Interests: Dr. Karpowicz investigates how circadian clocks influence cellular processes, with emphases on cancer prevention, regeneration, and environmental stress responses. His work bridges chronobiology, molecular biology, and ecology, using models like Drosophila, mice, and salmon to explore disease mechanisms. Articles highlight his exploration of BMAL1 gene functions, time-restricted feeding therapies, and circadian-driven environmental resilience in aquatic species. He has secured grants including the Early Researcher Award (2018) and NSERC funding (2020). His lab advises students like Rachna Patel and Kathyani Parasram, and collaborates with institutions like the Great Lakes Institute. Notable contributions include identifying circadian clock roles in colitis recovery and tumor suppression, and developing molecular tools for stress profiling in salmonids. Ongoing work explores circadian medicine and environmental adaptation strategies for aquatic organisms.

• Chronobiology
• Cancer Biology
• Gastroenterology
• +۳ مورد دیگر

Dr. Leng Chee Chang is a **Professor** in the **Department of Pharmaceutical Sciences** at the **Daniel K. Inouye College of Pharmacy (DKICP)**, University of Hawaii at Hilo. He holds dual affiliations with **Tropical Conservation Biology and Environmental Science (TCBES)**. His research focuses on natural products chemistry, particularly isolating bioactive compounds from tropical plants for applications in cancer prevention and infectious disease treatment. **Education**: B.S., Chemistry – University of Malaysia Sabah, Malaysia M.S. – University of Malaysia Sabah, Malaysia Ph.D., Natural Products Chemistry – College of Pharmacy, University of Illinois at Chicago **Research Interests**: Dr. Chang specializes in phytochemical evaluation of tropical plants to identify anti-inflammatory agents, anticancer compounds, and antimicrobial substances. His work bridges pharmacognosy and drug discovery, emphasizing sustainable use of local biodiversity. Key focus areas include Garcinia species, Physalis peruviana (poha berry), and Bocconia frutescens. **Grants & Awards**: He secured funding from the Hawaii Community Foundation (2017–2018) and USDA (2015–2020). Notable honors include the Teacher of the Year Award (2011, 2013) and the Excellence in Scholarly/Creative Activities Award (2017). **Patents**: Co-inventor of patents for sesquiterpenoid Stat3 inhibitors and withanolides with anti-inflammatory/anticancer properties.

• Natural Products Chemistry
• Pharmacognosy
• Bioactive Compounds
• +۳ مورد دیگر